CDEK
← All organizations

Luye Pharma

For profitWebsite ↗

Also known as: LUYE INNOMIND PHARMA | Luye Pharma | Luye Pharma. | Luye Pharma Group | Luye Pharma Group Ltd. | Luye Pharma US Ltd | Nanjing Luye Sike Pharmaceutical Co.,Ltd. | Shandong Boan Biotechnology Co., Ltd | Shan Dong Boan Biotechnology Co., Ltd | Shan Dong Boan Biotechnology Co., Ltd(Co-sponsor) | SHANDONG LUYE | Shandong Luye Pharmaceutical Co., Ltd. | Shangdon Boan Biotechnology Co Ltd | Shangdong Boan Biotechnology Co Ltd | Shang Dong Boan Biotechnology Co., Ltd (Co-sponsor)

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Feb 1, 2008

First marketed drug

Jan 13, 2023

Last known activity

Aug 20, 2025

Timeline

1990s

  1. Jun 1, 1994

    Luye Pharma— Founded

2000s

  1. Nov 23, 2007

    Wearnes Biotech and Medicals— Acquired

2020s

  1. Jan 13, 2023

    risperidone— Marketing Organization

  2. Jan 13, 2023

    risperidone— NDA Secondary Org

Drugs by trial phase (41 distinct, 87 trials)

Phase 2 (5 own, 0 via acquisition)

Other trials (0 own, 1 via acquisition)

Indications

Studied for

Marketed drugs (2)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Shanghai, CN Jun 1, 1994
Last known activity
Aug 20, 2025